Two-Dimensional 3 Tesla MRS of the Brain in HIV- Infected Youth
HIV 感染青少年大脑的二维 3 Tesla MRS
基本信息
- 批准号:7494784
- 负责人:
- 金额:$ 17.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAffectAgeAlgorithmsAmino AcidsAminobutyric AcidAminobutyric AcidsAnti-Retroviral AgentsAntioxidantsApplications GrantsAreaAttentionBasal GangliaBrainBrain regionCD4 Lymphocyte CountCD4 Positive T LymphocytesCerebrumChildCholineChronicChronic DiseaseClinicalCognitiveCreatineCrowdingCysteineDataDegenerative DisorderDementiaDetectionDevelopmentDimensionsDrug Metabolic DetoxicationEarly treatmentElevationEncephalitisEvaluationFutureGenderGliosisGlutamatesGlutamineGlutathioneGlycineGoalsGuidelinesHIVHIV InfectionsHealthHighly Active Antiretroviral TherapyImpaired cognitionIndividualInflammationInositolInvestigationLeftLongitudinal StudiesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMembraneMetabolicMothersMotorMotor ActivityN-acetylaspartateNervous System TraumaNeuraxisNeurogliaNeurologicNeuronsNeuropsychological TestsNeurotransmittersNoiseOxidative StressParkinson DiseasePathologyPatientsPenetrationPerformancePharmaceutical PreparationsPhosphorylcholinePlasmaPublic HealthQuality of lifeReactionReportingResearch PersonnelScoreSignal TransductionSpectrum AnalysisSystemTechniquesTestingTimeViral Load resultYouthage relatedantiretroviral therapybasecognitive functioncohortcomputerizedcritical developmental periodexecutive functiongamma-Aminobutyric Acidimprovedinterestmotor impairmentmyelinationneurocognitive testperformance testsphosphoethanolaminetooltransmission processtwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): HIV in adults and children has become a chronic illness and there is a critical need to develop noninvasive, reliable techniques to detect sub clinical involvement of the brain by HIV. Magnetic resonance spectroscopy (MRS) permits the study of HIV effects on cerebral metabolites, markers of neuronal and glial cell health. Most previous investigations have used 1.5 Tesla (T) scanners and one-dimensional MRS (1D-MRS) techniques. The primary goal of this study is to use an improved technique, a two-dimensional MRS technique (2D-MRS) on a 3 T scanner, to detect abnormal cerebral metabolites in HIV-infected patients, and to correlate abnormal cerebral metabolites with performance on neurocognitive tests, in order to better assess brain development and function in these individuals. A 3T scanner is expected to offer improved signal to noise ratios (SNR) and lower coefficients of variance compared to 1.5 T. The use of 2D-MRS allows the detection of many additional metabolites compared to traditional 1D-MRS by converting a crowded, overlapping 1D-MRS spectrum to a better resolved 2D spectrum through the addition of a spectral dimension. Of particular interest are GABA, an inhibitory neurotransmitter and myo-inositol (mI), a glial cell marker for which elevation suggests ongoing inflammation. Metabolite ratios to reference metabolites and metabolite concentrations will be determined. The 3 Tesla scanner combined with 2D-MRS also provides the ability to study glutathione (GSH), an important cellular antioxidant protector molecule that could assess central nervous system damage by the HIV virus. The specific aims of this study are to compare GABA, mI, choline groups, GSH and other metabolites in the right frontal brain region and right basal ganglia of 30 HIV-infected patients and 30 control subjects. Both of these areas of the brain have been documented to be involved in the central nervous system pathology of HIV. The hypotheses are that GABA and mI will be increased in HIV-infected patients while GSH will be decreased and that the changes in concentrations of these metabolites will correlate with poorer performance on neurocognitive tests of executive functioning, fine motor activity, and attention. In addition to the better assessment of brain development and function, reliable identification of perinatally HIV-infected youths with abnormal cerebral metabolites and sub clinical brain involvement by 2D-MRS (3T) may also direct earlier therapy than the current CD4 count criteria would indicate or changing existing HAART therapy to antiretroviral medications with improved CNS penetration. This study could potentially improve the quality of life of HIV-infected youths and preserve the health of the central nervous system. PUBLIC HEALTH RELEVANCE This study plans to identify metabolite markers of HIV involvement of the brain using noninvasive magnetic resonance spectroscopy in perinatally HIV-infected youths. Cerebral metabolite levels will be correlated with performance on neuropsychological tests and will identify involvement of the brain before clinical detection. Such results could dictate earlier therapy in children and youths with high CD4 cells or a change in antiretroviral medication to better treat HIV infection of the brain and improve the quality of life and neurological health of the millions of children worldwide infected with HIV from the mother.
描述(申请人提供):成人和儿童中的艾滋病毒已成为一种慢性病,迫切需要开发非侵入性、可靠的技术来检测艾滋病毒对大脑的亚临床影响。磁共振波谱(MRS)可以研究HIV对大脑代谢物的影响,这些代谢物是神经元和神经胶质细胞健康的标志。以前的大多数研究都使用了1.5特斯拉(T)扫描仪和一维MRS(1D-MRS)技术。这项研究的主要目的是使用一种改进的技术,在3T扫描仪上使用二维MRS技术(2D-MRS)来检测HIV感染患者的异常脑代谢产物,并将异常脑代谢产物与神经认知测试的表现相关联,以便更好地评估这些人的脑发育和功能。与1.5T相比,3T扫描仪有望提供更好的信噪比(SNR)和更低的变异系数。与传统的1D-MRS相比,2D-MRS的使用允许检测许多额外的代谢物,方法是通过增加光谱维度将拥挤、重叠的1D-MRS频谱转换为更好的分辨率2D频谱。特别令人感兴趣的是GABA,一种抑制性神经递质和肌肌醇(MI),一种神经胶质细胞标记物,升高表明正在发生炎症。代谢物与参考代谢物的比率和代谢物浓度将被确定。结合2D-MRS的3特斯拉扫描仪还提供了研究谷胱甘肽(GSH)的能力,谷胱甘肽是一种重要的细胞抗氧化保护分子,可以评估艾滋病毒对中枢神经系统的损害。本研究的具体目的是比较30例HIV感染者和30例对照组右侧额叶和右侧基底节的GABA、MI、胆碱基团、GSH等代谢物。大脑的这两个区域都被证明与艾滋病毒的中枢神经系统病理有关。假设艾滋病毒感染患者的GABA和mi将增加,而GSH将降低,这些代谢物浓度的变化将与执行功能、精细运动活动和注意力的神经认知测试中较差的表现相关。除了更好地评估大脑发育和功能外,2D-MRS(3T)可靠地识别出患有围产期艾滋病毒感染、大脑代谢异常和亚临床脑部受累的青少年,也可能指导比目前的CD4计数标准所表明的更早的治疗,或者将现有的HAART治疗改为具有更好的中枢神经系统渗透性的抗逆转录病毒药物。这项研究可能会改善感染艾滋病毒的年轻人的生活质量,并保护中枢神经系统的健康。公共卫生相关性这项研究计划在围产期感染HIV的年轻人中使用非侵入性磁共振波谱来确定HIV参与大脑的代谢物标记物。大脑代谢物水平将与神经心理测试的表现相关,并将在临床检测之前确定大脑是否参与其中。这一结果可能会要求对CD4细胞水平高的儿童和青少年进行更早的治疗,或者改变抗逆转录病毒药物,以更好地治疗脑部艾滋病毒感染,并改善全球数百万从母亲那里感染艾滋病毒的儿童的生活质量和神经健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET A KELLER其他文献
MARGARET A KELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET A KELLER', 18)}}的其他基金
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS HIV
抗逆转录病毒药物组合 HIV 的深入药代动力学研究
- 批准号:
8174501 - 财政年份:2009
- 资助金额:
$ 17.52万 - 项目类别:
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS
抗逆转录病毒药物组合的深入药代动力学研究
- 批准号:
7952269 - 财政年份:2008
- 资助金额:
$ 17.52万 - 项目类别:
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY
妊娠期间抗逆转录病毒治疗的药代动力学特性
- 批准号:
7606170 - 财政年份:2007
- 资助金额:
$ 17.52万 - 项目类别:
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN VERTICALLY HIV-INFEC
垂直 HIV 感染者形态和代谢异常的患病率
- 批准号:
7376075 - 财政年份:2005
- 资助金额:
$ 17.52万 - 项目类别:
MONTHER-INFANT RAPID INTERVENTION AT DELIVERY (MIRIAD)
分娩时的月婴快速干预 (MIRIAD)
- 批准号:
7206392 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN HIV-INFECTED CHILDREN
抗逆转录病毒治疗对艾滋病毒感染儿童身体成分的影响
- 批准号:
7206388 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
RANDOMIZED TRIAL OF PROTEASE INHIBITOR-INCLUDING VS. PRO
含蛋白酶抑制剂与含蛋白酶抑制剂的随机试验
- 批准号:
7042126 - 财政年份:2003
- 资助金额:
$ 17.52万 - 项目类别:
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN HIV-INFECTED CHILDREN
抗逆转录病毒治疗对艾滋病毒感染儿童身体成分的影响
- 批准号:
7042137 - 财政年份:2003
- 资助金额:
$ 17.52万 - 项目类别:
ACTG382 PHARMACOKINETICS, SAFETY, TOLERABILITY&ANTIVIRAL ACTIVITY OF
ACTG382 药代动力学、安全性、耐受性
- 批准号:
6416298 - 财政年份:2000
- 资助金额:
$ 17.52万 - 项目类别:
ACTG300 COMBINED ZIDOVUDINE LAMIVUDINE VS BETTER OF DDI MONOTHERAPY V
ACTG300 联合齐多夫定 拉米夫定 VS 更好的 DDI 单疗法 V
- 批准号:
6416325 - 财政年份:2000
- 资助金额:
$ 17.52万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




